Kaya Miah
0000-0002-0265-3529
German Cancer Research Center
5 papers found
Refreshing results…
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
Missing publications? Search for publications with a matching author name.